These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35400349)

  • 21. Curcumin Promotes Osteosarcoma Cell Death by Activating miR-125a/ERRα Signal Pathway.
    Chen P; Wang H; Yang F; Chen H; He W; Wang J
    J Cell Biochem; 2017 Jan; 118(1):74-81. PubMed ID: 27231954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wnt signaling in osteosarcoma.
    Lin CH; Ji T; Chen CF; Hoang BH
    Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
    Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin Analogue L48H37 Suppresses Human Osteosarcoma U2OS and MG-63 Cells' Migration and Invasion in Culture by Inhibition of uPA via the JAK/STAT Signaling Pathway.
    Lu KH; Wu HH; Lin RC; Lin YC; Lu PW; Yang SF; Yang JS
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin: An Insight into Molecular Pathways Involved in Anticancer Activity.
    Joshi P; Joshi S; Semwal D; Bisht A; Paliwal S; Dwivedi J; Sharma S
    Mini Rev Med Chem; 2021; 21(17):2420-2457. PubMed ID: 33480345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J; Zou Y; Jiang D
    Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of miR-21/RECK in the inhibition of osteosarcoma by curcumin.
    Zhou L; Lu Y; Liu JS; Long SZ; Liu HL; Zhang J; Zhang T
    Mol Cell Probes; 2020 Jun; 51():101534. PubMed ID: 32081769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Targets of Curcumin and Its Therapeutic Potential for Ovarian Cancer.
    Mohamadian M; Bahrami A; Moradi Binabaj M; Asgharzadeh F; Ferns GA
    Nutr Cancer; 2022; 74(8):2713-2730. PubMed ID: 35266849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of curcumin action: signal transduction.
    Shehzad A; Lee YS
    Biofactors; 2013; 39(1):27-36. PubMed ID: 23303697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcuma as an adjuvant in colorectal cancer treatment.
    Villegas C; Perez R; Sterner O; González-Chavarría I; Paz C
    Life Sci; 2021 Dec; 286():120043. PubMed ID: 34637800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PI3K/Akt signaling in osteosarcoma.
    Zhang J; Yu XH; Yan YG; Wang C; Wang WJ
    Clin Chim Acta; 2015 Apr; 444():182-92. PubMed ID: 25704303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells.
    Borges GA; Elias ST; Amorim B; de Lima CL; Coletta RD; Castilho RM; Squarize CH; Guerra ENS
    Phytother Res; 2020 Dec; 34(12):3311-3324. PubMed ID: 32628350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs.
    Wang M; Jiang S; Zhou L; Yu F; Ding H; Li P; Zhou M; Wang K
    Int J Biol Sci; 2019; 15(6):1200-1214. PubMed ID: 31223280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis.
    Liu L; Geng H; Mei C; Chen L
    Oxid Med Cell Longev; 2021; 2021():6661534. PubMed ID: 33859780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways.
    Liao Z; Nan G; Yan Z; Zeng L; Deng Y; Ye J; Zhang Z; Qiao M; Li R; Denduluri S; Wang J; Wei Q; Geng N; Zhao L; Lu S; Wang X; Zhou G; Luu HH; Haydon RC; He TC; Wang Z
    Curr Cancer Drug Targets; 2015; 15(8):726-38. PubMed ID: 26118906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity.
    Soghli N; Ferns GA; Sadeghsoltani F; Qujeq D; Yousefi T; Vaghari-Tabari M
    Biochem Pharmacol; 2022 Jul; 201():115094. PubMed ID: 35588853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R; Wu JX; Zhang Y; Che H; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melittin inhibits lung metastasis of human osteosarcoma: Evidence of wnt/β-catenin signaling pathway participation.
    Zhu H; Chen D; Xie X; Li Y; Fan T
    Toxicon; 2021 Jul; 198():132-142. PubMed ID: 33930393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.